BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2026 4:34:34 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 120771
Country United Kingdom
Received
2026-03-09 06:23
Peer-Review Started
2026-03-09 06:27
First Decision by Editorial Office Director
2026-04-23 05:07
Return for Revision
2026-04-23 05:07
Revised
2026-05-15 01:14
Publication Fee Transferred
Second Decision by Editor
2026-06-10 02:33
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-10 03:21
Articles in Press
2026-06-10 03:21
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-08-19 04:49
Publish the Manuscript Online
2026-09-01 04:34
ISSN 2150-5349 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature
Manuscript Source Invited Manuscript
All Author List Jonathan Soldera, Maria Antonia Selbach Pertile, Leticia Nodari Carobin, Daniel Jun Funatsu Brambilla and Eduardo Brambilla
ORCID
Author(s) ORCID Number
Jonathan Soldera http://orcid.org/0000-0001-6055-4783
Eduardo Brambilla http://orcid.org/0000-0002-4629-7095
Funding Agency and Grant Number
Corresponding Author Jonathan Soldera, MD, PhD, Department of Tutor, Gastroenterology and Acute Medicine, University of South Wales, Llantwit Road, Pontypridd, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com
Key Words Refractory inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Advanced combination therapy; Janus kinase inhibitors; Vedolizumab; Tofacitinib; Upadacitinib; Guselkumab; Case report
Core Tip Multi-refractory inflammatory bowel disease often stalls at a “near-working” partial response to an advanced therapy. This case series (n = 9) suggests that, in carefully selected patients, consolidating partial mechanistic control with structured optimization and add-on advanced combination therapy (an oral Janus kinase inhibitor plus a biologic) may convert incomplete response into deep remission and delay surgery. This approach requires phenotype-driven selection, objective reassessment anchored to endoscopic and biochemical endpoints, rigorous infection exclusion, close monitoring, and predefined stopping rules - recognizing that timely colectomy remains appropriate when objective control fails.
Publish Date 2026-09-01 04:34
Citation

Soldera J, Pertile MAS, Carobin LN, Brambilla DJF, Brambilla E. Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. World J Gastrointest Pharmacol Ther 2026; 17(3): 120771

URL https://www.wjgnet.com/2150-5349/full/v17/i3/120771.htm
DOI https://doi.org/10.4292/wjgpt.120771
Full Article (PDF) WJGPT-17-120771-with-cover.pdf
CARE Checklist–2016 120771-CARE-Checklist-2016.pdf
Manuscript File 120771_Auto_Edited_013112.docx
Answering Reviewers 120771-answering-reviewers.pdf
Audio Core Tip 120771-audio.ogg
Conflict-of-Interest Disclosure Form 120771-conflict-of-interest-statement.pdf
Copyright License Agreement 120771-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s) 120771-informed-consent-statement.pdf
Peer-review Report 120771-peer-reviews.pdf
Scientific Misconduct Check 120771-scientific-misconduct-check.png
CrossCheck Report 120771-crosscheck-report.pdf